Tobias Wirenfeldt Klausen

Results of NOPHO ALL2008 treatment for patients aged 1–45 years with acute lymphoblastic leukemia

N. Toft, Henrik Birgens, Jonas Abrahamsson et al. · Leukemia · 2017 · 418 citations · Full text

Medicine, Hematology, Oncology +6

A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma

Julie Westerlin Kjeldsen, Cathrine Lund Lorentzen, Evelina Martinenaite et al. · Nature Medicine · 2021 · 209 citations · Full text

Medicine, Immunology, Oncology +17

Rituximab in chronic cold agglutinin disease: a prospective study of 20 patients

Claudia Schöllkopf, Lars Kjeldsen, Ole Weiss Bjerrum et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2005 · 174 citations

Life Sciences, Hematology, Immunology +14

Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia

Sif Gudbrandsdottir, Henrik Birgens, Henrik Frederiksen et al. · Blood · 2013 · 174 citations · Full text

Life Sciences, Hematology, Immunology +7

A phase <scp>III</scp> randomized trial comparing glucocorticoid monotherapy <i>versus</i> glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia

Henrik Birgens, Henrik Frederiksen, Hans Carl Hasselbalch et al. · British Journal of Haematology · 2013 · 173 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17